Notice for International Patients & Caregivers

English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.

Provincial Landscape
Snapshot: 2026-09-04

Beijing Multiple Myeloma Active Trials & Centers

As of 2026-09-04, there are 49 active clinical trials for multiple myeloma hosted across 27 tertiary medical centers in Beijing (including Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing Chao-Yang Hospital, Capital Medical University, Peking University First Hospital, etc.).

Active Trials
49
Hospitals
27
Therapies
CAR-T Cell Therapy / Bispecific & Multispecific Antibodies / Monoclonal Antibodies / Oral Small-Molecule Agents

Participating Medical Centers (27)

Peking Union Medical College Hospital, Chinese Academy of Medical SciencesBeijing Chao-Yang Hospital, Capital Medical UniversityPeking University First HospitalPeking Union Medical College HospitalPeking University People's HospitalPeking University Third HospitalBeijing GoBroad HospitalBeijing Chaoyang Hospital (West Campus), Capital Medical UniversityXuanwu Hospital, Capital Medical UniversityCancer Hospital, Chinese Academy of Medical SciencesBeijing Jishuitan HospitalBeijing Boren HospitalBeijing Tongren Hospital, Capital Medical University首都医科大学附属北京朝阳医院东院首都医科大学附属北京朝阳医院西院Fuxing Hospital, Capital Medical UniversityBeijing Gobroad Boren HospitalBeijing Jishuitan Hospital, Capital Medical UniversityBeijing Tongren HospitalThe Fifth Medical Center of the PLA General HospitalPeking University Cancer HospitalChinese PLA General Hospital (301 Hospital)Beijing Chaoyang HospitalChina-Japan Friendship HospitalBeijing Shijitan Hospital, Capital Medical UniversityBeijing Chaoyang Hospital, Capital Medical UniversityBeijing Hospital

Active Studies in Beijing (49)

Population synthesized by CMDN

Showing 0 published English records of 49 registry trials.

All 49 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.